negative regulation of chemokine (C-X-C motif) ligand 2 production
epidermal cell differentiation
cellular response to retinoic acid
negative regulation of protein kinase B signaling
negative regulation of muscle hyperplasia
negative regulation of smooth muscle cell proliferation
positive regulation of protein metabolic process
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process
regulation of axon regeneration
cellular response to peptide
regulation of transcription, DNA-templated
positive regulation of hemoglobin biosynthetic process
response to retinoic acid
somatic stem cell population maintenance
cellular response to laminar fluid shear stress
regulation of transcription by RNA polymerase II
cell differentiation
epidermis morphogenesis
positive regulation of nitric oxide biosynthetic process
cellular response to growth factor stimulus
cellular response to organic cyclic compound
post-embryonic hemopoiesis
negative regulation of transcription by RNA polymerase II
transcription by RNA polymerase II
response to organic substance
negative regulation of gene expression
negative regulation of response to cytokine stimulus
transcription, DNA-templated
negative regulation of DNA-binding transcription factor activity
negative regulation of phosphatidylinositol 3-kinase signaling
stem cell population maintenance
negative regulation of cell migration involved in sprouting angiogenesis
positive regulation of gene expression
negative regulation of cell migration
regulation of cell population proliferation
post-embryonic camera-type eye development
regulation of phosphatidylinositol 3-kinase activity
positive regulation of telomerase activity
canonical Wnt signaling pathway
negative regulation of ERK1 and ERK2 cascade
regulation of cell differentiation
mesodermal cell fate determination
negative regulation of heterotypic cell-cell adhesion
negative regulation of transcription, DNA-templated
negative regulation of NF-kappaB transcription factor activity
cellular response to cycloheximide
negative regulation of inflammatory response
fat cell differentiation
positive regulation of transcription by RNA polymerase II
negative regulation of cell population proliferation
cellular response to hydrogen peroxide
negative regulation of leukocyte adhesion to arterial endothelial cell
positive regulation of core promoter binding
cellular response to leukemia inhibitory factor
negative regulation of angiogenesis
pri-miRNA transcription by RNA polymerase II
negative regulation of G1/S transition of mitotic cell cycle
positive regulation of transcription, DNA-templated
positive regulation of sprouting angiogenesis
Sources:Amigo / QuickGO
Orthologs
Species
Human
Mouse
Entrez
9314
16600
Ensembl
ENSG00000136826
ENSMUSG00000003032
UniProt
O43474
Q60793
RefSeq (mRNA)
NM_001314052 NM_004235
NM_010637
RefSeq (protein)
NP_001300981 NP_004226
NP_034767
Location (UCSC)
Chr 9: 107.48 – 107.49 Mb
Chr 4: 55.53 – 55.53 Mb
PubMed search
[3]
[4]
Wikidata
View/Edit Human
View/Edit Mouse
Kruppel-like factor 4 (KLF4; gut-enriched Krüppel-like factor or GKLF) is a member of the KLF family of zinc finger transcription factors, which belongs to the relatively large family of SP1-like transcription factors.[5][6][7] KLF4 is involved in the regulation of proliferation, differentiation, apoptosis and somatic cell reprogramming. Evidence also suggests that KLF4 is a tumor suppressor in certain cancers, including colorectal cancer.[8] It has three C2H2-zinc fingers at its carboxyl terminus that are closely related to another KLF, KLF2.[6] It has two nuclear localization sequences that signals it to localize to the nucleus.[9] In embryonic stem cells (ESCs), KLF4 has been demonstrated to be a good indicator of stem-like capacity. It is suggested that the same is true in mesenchymal stem cells (MSCs).
In humans, the protein is 513 amino acids, with a predicted molecular weight of approximately 55kDa, and is encoded by the KLF4 gene.[10] The KLF4 gene is conserved in chimpanzee, rhesus monkey, dog, cow, mouse, rat, chicken, zebrafish, and frog.[11] KLF4 was first identified in 1996.[12]
^ abcGRCh38: Ensembl release 89: ENSG00000136826 – Ensembl, May 2017
^ abcGRCm38: Ensembl release 89: ENSMUSG00000003032 – Ensembl, May 2017
^"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^Black AR, Black JD, Azizkhan-Clifford J (August 2001). "Sp1 and krüppel-like factor family of transcription factors in cell growth regulation and cancer". Journal of Cellular Physiology. 188 (2): 143–60. doi:10.1002/jcp.1111. PMID 11424081. S2CID 39150180.
^ abDang DT, Pevsner J, Yang VW (November 2000). "The biology of the mammalian Krüppel-like family of transcription factors". The International Journal of Biochemistry & Cell Biology. 32 (11–12): 1103–21. doi:10.1016/s1357-2725(00)00059-5. PMC 2754176. PMID 11137451.
^Shields JM, Yang VW (July 1997). "Two potent nuclear localization signals in the gut-enriched Krüppel-like factor define a subfamily of closely related Krüppel proteins". The Journal of Biological Chemistry. 272 (29): 18504–7. doi:10.1074/jbc.272.29.18504. PMC 2268085. PMID 9218496.
^"Entrez Gene: KLF4 Kruppel-like factor 4 (gut)".
^"Kruppel-like factor 4".
^Shields JM, Christy RJ, Yang VW (August 1996). "Identification and characterization of a gene encoding a gut-enriched Krüppel-like factor expressed during growth arrest". The Journal of Biological Chemistry. 271 (33): 20009–17. doi:10.1074/jbc.271.33.20009. PMC 2330254. PMID 8702718.
Kruppel-like factor 4 (KLF4; gut-enriched Krüppel-like factor or GKLF) is a member of the KLF family of zinc finger transcription factors, which belongs...
that the introduction of four specific genes (named Myc, Oct3/4, Sox2 and Klf4), collectively known as Yamanaka factors, encoding transcription factors...
but could in the end reduce it to 4 transcription factors – Sox2, Oct4, Klf4 and c-Myc. The 2012 Nobel Prize in Physiology or Medicine was awarded jointly...
induced expression of four transcription factors Oct4, Sox2, c-Myc, and Klf4 (Yamanaka factors) is sufficient to create pluripotent (iPS) cells from adult...
Compared to OSKM (Oct4, Sox2, Klf4 and c-Myc) that show abnormal imprinting and differentiation patterns, SKM (Sox2, Klf4 and c-Myc) reprogramming generates...
cells are generated by the transcription factors Myc, Oct3/4, Sox2, and Klf4. Worobec SM (2008). "Treatment of leprosy/Hansen's disease in the early 21st...
are present in about one-fourth of meningiomas. Mutations in the TRAF7, KLF4, AKT1, and SMO genes are commonly expressed in benign skull-base meningiomas...
2006 using mouse fibroblasts and four transcription factors, Oct4, Sox2, Klf4 and c-Myc; this technique, called reprogramming, later earned Shinya Yamanaka...
return to a 'stem-like' state alongside transcription factors Oct4, Sox2 and Klf4. It has since been shown that it is possible to generate iPSCs without c-Myc...
studies have revealed several mechanosensitive genes, such as HoxA5, Klf3, and Klf4, whose promoters were hypermethylated by disturbed blood flow, but rescued...
University. They used the transcription factors Oct3/4, Sox2, c-Myc, and Klf4 to reprogram mouse fibroblast cells into pluripotent cells. Subsequent work...
stem cell-like state by the introduction of four factors (Oct3/4, Sox2, Klf4, and c-Myc). iPS cells have the ability to self-renew indefinitely and contribute...
can be induced by the delivery of four factors (Oct3/4, Sox2, c-Myc, and Klf4) to differentiated cells. Utilizing the four genes previously listed, the...
downstream of the JAK-STAT signaling pathway and subsequent activation of Klf4 (a member of the family of Kruppel-like factors). Oct-4, Sox2 and Nanog positively...
discovered, could be recapitulated (in mice) by defined factors (Oct4, Sox2, Klf4, and c-Myc) to generate induced pluripotent stem cells (iPSCs). Other combinations...
December A gene therapy based on three transcription factors, Oct4, Sox2, and Klf4 (OSK), is shown to provide sustained vision recovery in mice affected by...